- Patient genders, risks, therapies, and local findings.
| Variables | Group A | Group B | Total |
|---|---|---|---|
| Female | 21 (63.3) | 19 (70.0) | 40 (66.7) |
| Cigarette smoking | 13 (36.7) | 18 (60.0) | 31 (51.7) |
| Insulin | 23 (76.7) | 21 (70.0) | 44 (73.3) |
| ACE inhibitors | 24 (80.0) | 27 (90.0) | 51 (85.0) |
| Statins | 23 (76.7) | 29 (96.7) | 52 (86.7) |
| Antithrombotics | 27 (90.0) | 30 (100) | 57 (95.0) |
| Antibiotics | 26 (86.7) | 26 (86.7) | 52 (85.0) |
| Dry gangrene | 8 (26.7) | 7 (23.3) | 15 (25.0) |
| Wet gangrene | 22 (73.3) | 23 (76.7) | 45 (75.0) |
| First amputation | 18 (60.0) | 20 (66.7) | 38 (63.3) |
| Fingers re-amputation | 8 (26.7) | 1 (3.3) | 9 (15.0) |
Values are presented as numbers and percentages (%). No significant difference between groups with respect to gender, risks, therapies, or local findings were noted.